Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
James Hardie Industries
JHX
$18B
| $81.5M | ﹤0.01% |
3,925,740
-472,748
| -11% | -$9.48M |
|
1627
Euronet Worldwide
EEFT
$2.64B
| $81.4M | ﹤0.01% |
1,069,863
-55,343
| -5% | -$4.31M |
|
1628
Rambus
RMBS
$10.5B
| $81.3M | ﹤0.01% |
885,092
-180,712
| -17% | -$17.8M |
|
1629
Cullen/Frost Bankers
CFR
$10.3B
| $81.3M | ﹤0.01% |
641,890
+164,854
| +35% | +$20.7M |
|
1630
Transmedics
TMDX
$3.1B
| $81.2M | ﹤0.01% |
667,761
+119,942
| +22% | +$15.1M |
|
1631
Trex
TREX
$5.07B
| $81.2M | ﹤0.01% |
2,313,285
+713,054
| +45% | +$28.8M |
|
1632
Urban Outfitters
URBN
$6.8B
| $81M | ﹤0.01% |
1,076,797
-1,406,817
| -57% | -$99.5M |
|
1633
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.28B
| $81M | ﹤0.01% |
3,603,315
+94,053
| +3% | +$2.12M |
|
1634
Tencent Music
TME
$14.3B
| $80.9M | ﹤0.01% |
4,614,530
+1,403,559
| +44% | +$28.5M |
|
1635
Calamos Strategic Total Return Fund
CSQ
$3.35B
| $80.9M | ﹤0.01% |
4,211,288
-89,146
| -2% | -$1.7M |
|
1636
State Street SPDR S&P Bank ETF
KBE
$1.73B
| $80.7M | ﹤0.01% |
1,330,255
-173,543
| -12% | -$10.2M |
|
1637
Globus Medical
GMED
$11.4B
| $80.7M | ﹤0.01% |
924,375
+83,371
| +10% | +$6.33M |
|
1638
Ionis Pharmaceuticals
IONS
$9.21B
| $80.7M | ﹤0.01% |
1,019,906
-160,410
| -14% | -$12.1M |
|
1639
Western Union
WU
$2.2B
| $80.5M | ﹤0.01% |
8,648,431
+2,666,265
| +45% | +$23.5M |
|
1640
Academy Sports + Outdoors
ASO
$3.07B
| $80.5M | ﹤0.01% |
1,610,782
+263,267
| +20% | +$13.1M |
|
1641
Cytokinetics
CYTK
$10.6B
| $80.4M | ﹤0.01% |
1,265,301
-255,885
| -17% | -$15.9M |
|
1642
AGNC Investment
AGNC
$12.9B
| $80.3M | ﹤0.01% |
7,491,585
+1,462,468
| +24% | +$15M |
|
1643
Exponent
EXPO
$3.25B
| $80.2M | ﹤0.01% |
1,154,210
+39,865
| +4% | +$2.8M |
|
1644
Invesco Dorsey Wright Momentum ETF
PDP
$1.49B
| $80.1M | ﹤0.01% |
688,024
+6,276
| +0.9% | +$739K |
|
1645
Silgan Holdings
SLGN
$4.35B
| $80M | ﹤0.01% |
1,980,712
+207,766
| +12% | +$8.43M |
|
1646
Global X Copper Miners ETF NEW
COPX
$8.25B
| $79.9M | ﹤0.01% |
1,113,573
+68,362
| +7% | +$4.38M |
|
1647
Hayward Holdings
HAYW
$3.3B
| $79.6M | ﹤0.01% |
5,149,647
+25,470
| +0.5% | +$403K |
|
1648
CNO Financial Group
CNO
$5.05B
| $79.5M | ﹤0.01% |
1,870,982
+317,690
| +20% | +$12.9M |
|
|
MEGI
1649
MainStay CBRE Global Infrastructure Megatrends Term Fund
MEGI
$784M
| $79.4M | ﹤0.01% |
5,769,365
+584,119
| +11% | +$8.28M |
|
|
PRMB
1650
Primo Brands
PRMB
$8.56B
| $79.3M | ﹤0.01% |
4,850,797
+2,698,047
| +125% | +$49.9M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.